5th EJP RD Joint Transnational Call for Rare Diseases Research Project (JTC 2023)
Basic Information
Natural History Studies addressing unmet needs in Rare Diseases
Network | EJP RD | ||||||||
Website | https://www.ejprarediseases.org/joint-transnational-call-2023/ | ||||||||
Aim of the joint call | The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with expected impact to use the results in the future for benefit of patients. | ||||||||
Type of joint call | Two Stages - Call with pre-proposals and full proposals submissions | ||||||||
Events |
|
||||||||
Is call co-funded? | No | ||||||||
Call follow up funding | n/a | ||||||||
Call reasons | n/a | ||||||||
Research fields |
|
||||||||
Type of research | n/a | ||||||||
Target groups | n/a | ||||||||
Participating networks | n/a |
Organisations Participating
Funded Projects
Acronym | Title | Start | End | No. partners |
---|---|---|---|---|
3D-GATA2 | 3D-GATA2 : How GATA2 deficiency affects development and dise... | 6 | ||
ADTKD-Net | AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE-Net - A... | 6 | ||
ARTEMIS | Ataxia CP-advancing diagnosis to enhance chances for targete... | 6 | ||
CADANHIS | CADASIL-Natural HIStory | 7 | ||
CARE4ARID1B | Developmental Trajectories in ARID1B-Related Disorder – a M... | 8 | ||
GENOMIT 5 | GENOMIT: Understanding variation in natural history of mitoc... | 7 | ||
GNAO1-EU | European Natural History Study and search for novel biomarke... | 7 | ||
IEI-Haem | The interplay between Inborn Error of Immunity and blood dis... | 7 | ||
NARRATIVE | Natural history, quality of life and patient-reported outcom... | 8 | ||
OptiMyG | Characterization and optimization of myasthenia gravis care | 7 | ||
PRECISE | Biomarkers and outcome PREdictors of paediatriC nephrotIc sy... | 7 | ||
PROMOT | Performing a Rare disease-Oriented Master Observational Tria... | 8 | ||
RiTA | PortoSinusoidal Vascular Disease: Risk stratification & Ther... | 6 |